Chesapeake Wealth Management Abbott Laboratories Transaction History

Chesapeake Wealth Management

  • $297 Million
  • Q2 2025

A detailed history of Chesapeake Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Chesapeake Wealth Management holds 5,090 shares of ABT stock, worth $651,570. This represents 0.23% of its overall portfolio holdings.

Number of Shares
5,090
Previous 5,190 1.93%
Holding current value
$651,570
Previous $688,000 0.58%
% of portfolio
0.23%
Previous 0.25%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025
SELL
$123.95 - $138.08 $12,395 - $13,808
-100 Reduced 1.93%
5,090 $692,000
Q1 2025

May 08, 2025
SELL
$111.1 - $140.22 $91,102 - $114,980
-820 Reduced 13.64%
5,190 $688,000
Q4 2024

Jan 16, 2025
SELL
$111.93 - $119.39 $28,430 - $30,325
-254 Reduced 4.05%
6,010 $679,000
Q3 2024

Nov 07, 2024
SELL
$100.07 - $118.13 $8,005 - $9,450
-80 Reduced 1.26%
6,264 $714,000
Q2 2024

Aug 13, 2024
SELL
$100.73 - $112.44 $92,772 - $103,557
-921 Reduced 12.68%
6,344 $659,000
Q1 2024

May 07, 2024
SELL
$109.52 - $120.96 $42,712 - $47,174
-390 Reduced 5.09%
7,265 $825,000
Q4 2023

Feb 12, 2024
SELL
$90.19 - $110.4 $59,886 - $73,305
-664 Reduced 7.98%
7,655 $842,000
Q3 2023

Nov 16, 2023
SELL
$95.53 - $114.62 $22,354 - $26,821
-234 Reduced 2.74%
8,319 $805,000
Q2 2023

Aug 01, 2023
SELL
$100.78 - $112.29 $108,439 - $120,824
-1,076 Reduced 11.17%
8,553 $932,000
Q1 2023

Apr 25, 2023
SELL
$96.86 - $114.01 $5,811 - $6,840
-60 Reduced 0.62%
9,629 $975,000
Q4 2022

Feb 23, 2023
SELL
$95.06 - $111.52 $76,143 - $89,327
-801 Reduced 7.64%
9,689 $1.06 Million
Q3 2022

Oct 28, 2022
SELL
$96.76 - $112.03 $14,030 - $16,244
-145 Reduced 1.36%
10,490 $1.02 Million
Q2 2022

Jul 21, 2022
SELL
$102.07 - $123.37 $10,207 - $12,337
-100 Reduced 0.93%
10,635 $1.16 Million
Q1 2022

Apr 19, 2022
SELL
$114.02 - $139.04 $34,776 - $42,407
-305 Reduced 2.76%
10,735 $1.27 Million
Q4 2021

Feb 03, 2022
BUY
$115.53 - $141.46 $231 - $282
2 Added 0.02%
11,040 $1.55 Million
Q3 2021

Oct 26, 2021
SELL
$116.66 - $129.06 $149,208 - $165,067
-1,279 Reduced 10.38%
11,038 $1.3 Million
Q2 2021

Jul 29, 2021
SELL
$105.79 - $124.53 $133,401 - $157,032
-1,261 Reduced 9.29%
12,317 $1.43 Million
Q1 2021

Apr 26, 2021
SELL
$108.84 - $128.23 $63,344 - $74,629
-582 Reduced 4.11%
13,578 $1.63 Million
Q4 2020

Feb 05, 2021
SELL
$105.0 - $114.42 $89,355 - $97,371
-851 Reduced 5.67%
14,160 $1.55 Million
Q3 2020

Nov 12, 2020
SELL
$91.64 - $111.29 $18,786 - $22,814
-205 Reduced 1.35%
15,011 $1.63 Million
Q2 2020

Aug 11, 2020
SELL
$76.57 - $98.0 $13,629 - $17,444
-178 Reduced 1.16%
15,216 $1.39 Million
Q1 2020

Apr 29, 2020
SELL
$62.82 - $91.86 $186,512 - $272,732
-2,969 Reduced 16.17%
15,394 $1.21 Million
Q4 2019

Jan 29, 2020
SELL
$78.51 - $87.4 $511,571 - $569,498
-6,516 Reduced 26.19%
18,363 $1.6 Million
Q3 2019

Oct 25, 2019
BUY
$81.84 - $88.74 $272,854 - $295,859
3,334 Added 15.47%
24,879 $2.08 Million
Q2 2019

Aug 01, 2019
BUY
$72.88 - $85.0 $332,697 - $388,025
4,565 Added 26.88%
21,545 $1.81 Million
Q1 2019

Apr 17, 2019
BUY
$66.22 - $80.06 $242,365 - $293,019
3,660 Added 27.48%
16,980 $1.36 Million
Q4 2018

Feb 06, 2019
SELL
$65.56 - $74.27 $47,399 - $53,697
-723 Reduced 5.15%
13,320 $963,000
Q3 2018

Nov 14, 2018
SELL
$60.81 - $73.36 $5,472 - $6,602
-90 Reduced 0.64%
14,043 $1.03 Million
Q2 2018

Aug 07, 2018
SELL
$57.57 - $63.54 $16,234 - $17,918
-282 Reduced 1.96%
14,133 $862,000
Q1 2018

Jun 04, 2018
BUY
$56.27 - $63.62 $811,132 - $917,082
14,415 New
14,415 $863,000

Others Institutions Holding ABT

# of Institutions
3,577
Shares Held
1.38B
Call Options Held
9.72M
Put Options Held
8.83M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Chesapeake Wealth Management Portfolio

Follow Chesapeake Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email